TNT of SCRT+CAPOX vs SCRT+CAPOXIRI for Locally Advanced Rectal Cancer

This trial is a multicenter randomized Phase III study to verify the superiority of short-course preoperative radiation (SCRT) and CAPOXIRI over SCRT and CAPOX as preoperative treatments for locally advanced rectal cancer.

Trial Details

NCT ID
NCT05646511
Phase
PHASE3
Sponsor
National Cancer Center Hospital East
Status
RECRUITING
Cancer Type
Colorectal Cancer
Interventions
  • SCRT
  • CAPOX
  • CAPOXIRI
Locations (sample)
  • Chiba, Japan|35.6,140.11667
  • Ehime, Japan
  • Fukuoka, Japan|33.6,130.41667
  • Fukuoka, Japan|33.6,130.41667
  • Fukuoka, Japan|33.6,130.41667

Key Eligibility Criteria

  • The content of this research was fully explained, and written informed consent was obtained from the subject.
  • Histologically confirmed rectal adenocarcinoma.
  • Radical resection is clinically possible without any distant metastases on imaging studies.
  • Age of 18 years or older on the date of consent acquisition.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Colorectal Cancer Trials on Trialify →